Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02917460 · ClinicalTrials.gov registry record · NA
Rady Children's Institute Genomic Biorepository
A NA study of Genetic Diseases, sponsored by Rady Pediatric Genomics & Systems Medicine Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 102,000
- Enrollment target
- 1
- Study location
NCT02917460: Recruiting NA study of Genetic Diseases, sponsored by Rady Pediatric Genomics & Systems Medicine Institute.
NCT02917460 is a NA study of Genetic Diseases that is actively recruiting participants, run by Rady Pediatric Genomics & Systems Medicine Institute. The registered enrollment target is 102,000 participants, above the 2,195-participant average among 3 other Genetic Diseases trials with a reported enrollment target (4547% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02917460, a NA study of Genetic Diseases, is actively recruiting participants, sponsored by Rady Pediatric Genomics & Systems Medicine Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 102,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Rady Children's Institute for Genomic Medicine (RCI) will collect biological samples (such as blood), derived genomic sequences (from DNA and RNA), and clinical features in a Biorepository as a standardized resource for future research studies. The purpose of the Genomic Institute Biorepository is to provide consented samples and data for basic and clinical research related to the genomic cause and treatment of childhood disease, and, in the future, as reference (Quality Control) data to improve the ability to make clinical diagnoses or clinical decisions. In addition, the Biorepository will provide a mechanism for making a diagnosis of a genetic disease. That is, once genomic sequences have been derived from biological samples, they will be immediately analyzed. If a genetic disease is identified that appears to explain an affected child's clinical features, then those results will be confirmed by the medically accepted standard, and placed in the electronic health record.
Primary Outcome
Establishment of a Biorepository for genomic/precision medicine use in pediatric population. This will make samples available to study rare genetic disorders, screening methods, diagnostic methods, other "omics", and bench research for possible treatments.
Conditions Studied
Interventions
- GENETIC Genomic sequencing and molecular diagnostic results, if any
Study Locations (1)
California
- Rady Pediatric Genomics & Systems Medicine Institute - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102,000 participants |
| Start Date | 2016-07 |
| Est. Completion | 2050-12 |
| Phase | NA |
What NCT02917460 shows while recruiting
NCT02917460 is an interventional study that assigns participants to a tested intervention. Its 102,000 participants enrollment target places it among the larger protocols in the corpus, above the 2,195-participant average among 3 other Genetic Diseases trials with a reported enrollment target (4547% higher).
The record links to 1 condition, with Genetic Diseases appearing as the primary indexed condition, and to 1 intervention - of which Genomic sequencing and molecular diagnostic results, if any is the first listed.
NCT02917460 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02917460 about?
NCT02917460 is a clinical study titled "Rady Children's Institute Genomic Biorepository". Rady Children's Institute for Genomic Medicine (RCI) will collect biological samples (such as blood), derived genomic sequences (from DNA and RNA), and clinical features in a Biorepository as a standardized resource for future research studies. The purpose of the Genomic Institute Biorepository is t...
What is the current status of trial NCT02917460?
This trial is currently recruiting. It is a NA study. The enrollment target is 102,000 participants. The study started on 2016-07. Estimated completion is 2050-12.
What conditions does trial NCT02917460 study?
This clinical trial studies the following conditions: Genetic Diseases.
What interventions are being tested in trial NCT02917460?
The interventions under investigation include: Genomic sequencing and molecular diagnostic results, if any (GENETIC).
Who is sponsoring clinical trial NCT02917460?
This trial is sponsored by Rady Pediatric Genomics & Systems Medicine Institute, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02917460 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Genetic Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05741112 · 100,500 participants · NA
The Long COVID-19 Wearable Device Study
- NCT02620852 · 100,000 participants · NA
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
- NCT03277365 · 100,000 participants · NA
MyGeneRank: A Digital Platform for Next-Generation Genetic Studies
- NCT04281823 · 100,000 participants
DeBakey Cardiovascular Magnetic Resonance Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia